Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Validation of an EHR-based Model to Predict Pancreatic Cancer Risk Using Multicenter US Data

NCT05973331 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.

NCT NCT05973331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05973331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Validation of an EHR-based Model to Predict Pancreatic Cancer Risk Using Multicenter US Data
Lead sponsor
Beth Israel Deaconess Medical Center
Phase
Observational
Overall status
Active, not recruiting
Start date
April 21, 2023
Completion date
April 30, 2028
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic adenocarcinoma, predictive cancer model